Home » FDA Announces Bayer Recall of Blood Glucose Monitoring System
FDA Announces Bayer Recall of Blood Glucose Monitoring System
The FDA July 16 issued a MedWatch notice announcing that Bayer Healthcare initiated a Class 1 recall of its Ascensia Contour blood glucose monitoring system.
Device Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May